ATE390440T1 - Neuroaktive peptide - Google Patents

Neuroaktive peptide

Info

Publication number
ATE390440T1
ATE390440T1 AT97929027T AT97929027T ATE390440T1 AT E390440 T1 ATE390440 T1 AT E390440T1 AT 97929027 T AT97929027 T AT 97929027T AT 97929027 T AT97929027 T AT 97929027T AT E390440 T1 ATE390440 T1 AT E390440T1
Authority
AT
Austria
Prior art keywords
neuroactive peptides
val
neuroactive
peptides
angiotensin
Prior art date
Application number
AT97929027T
Other languages
English (en)
Inventor
Frederick Mendelsohn
Siew Chai
Ingrid Moeller
Peter Aldred
Ian Smith
Rebecca Lew
Original Assignee
Florey Howard Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florey Howard Inst filed Critical Florey Howard Inst
Application granted granted Critical
Publication of ATE390440T1 publication Critical patent/ATE390440T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97929027T 1996-07-09 1997-07-09 Neuroaktive peptide ATE390440T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO0893A AUPO089396A0 (en) 1996-07-09 1996-07-09 Neuroactive peptide

Publications (1)

Publication Number Publication Date
ATE390440T1 true ATE390440T1 (de) 2008-04-15

Family

ID=3795208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97929027T ATE390440T1 (de) 1996-07-09 1997-07-09 Neuroaktive peptide

Country Status (9)

Country Link
US (1) US7026280B2 (de)
EP (1) EP0917535B1 (de)
JP (1) JP4275738B2 (de)
AT (1) ATE390440T1 (de)
AU (1) AUPO089396A0 (de)
CA (1) CA2259137A1 (de)
DE (1) DE69738600T2 (de)
NZ (1) NZ333632A (de)
WO (1) WO1998001465A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050020519A1 (en) * 2001-08-02 2005-01-27 Albiston Anthony L. Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity
EG23584A (en) * 2003-11-11 2006-09-11 Ali Mokhtar Al-Hossary Amr Elimination of myoglobin from blood using an i v filter
WO2007024946A2 (en) * 2005-08-23 2007-03-01 Wyeth Methods for the treatment of anxiety and for identification of anxiolytic agents
US9066901B2 (en) * 2006-07-07 2015-06-30 Washington State University C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
EP3935944A1 (de) 2013-03-15 2022-01-12 University Of Southern California, USC Stevens Verbindungen zur behandlung von erkrankungen des bewegungsapparats
WO2014151338A1 (en) * 2013-03-15 2014-09-25 University Of Southern California Methods for treating multiple sclerosis
RU2727162C1 (ru) * 2019-09-17 2020-07-21 Общество С Ограниченной Ответственностью "Герофарм" Композиция полипептидов, обладающая свойством нормализовать функции головного мозга
RU2727167C1 (ru) * 2019-09-17 2020-07-21 Общество С Ограниченной Ответственностью "Герофарм" Композиция полипептидов, обладающая свойством нормализовать функции головного мозга

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits
US5599907A (en) * 1989-05-10 1997-02-04 Somatogen, Inc. Production and use of multimeric hemoglobins
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof

Also Published As

Publication number Publication date
EP0917535A1 (de) 1999-05-26
DE69738600T2 (de) 2009-07-23
AUPO089396A0 (en) 1996-08-01
EP0917535B1 (de) 2008-03-26
JP2001504803A (ja) 2001-04-10
DE69738600D1 (de) 2008-05-08
NZ333632A (en) 2000-06-23
US20020147129A1 (en) 2002-10-10
CA2259137A1 (en) 1998-01-15
WO1998001465A1 (en) 1998-01-15
EP0917535A4 (de) 2001-11-21
JP4275738B2 (ja) 2009-06-10
US7026280B2 (en) 2006-04-11

Similar Documents

Publication Publication Date Title
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
DE69833948D1 (de) Aktives system zur frühen zerstörung von schleppwirbeln
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
ATE218579T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
ATE197307T1 (de) Neuroaktive peptide
DE69938786D1 (de) Die verwendung von peptiden von il-2 und peptid-derivaten als therapeutische wirkstoffe
ID24520A (id) Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
PT896615E (pt) Peptido proveniente de uma forma soluvel de acetilcolinesterase activo como modulador dos canais de calcio
DE69839566D1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
BR9813817A (pt) Análogos de hemiasterlina
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE390440T1 (de) Neuroaktive peptide
DK0687180T3 (da) Fremgangsmåde til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-anti
ATE385805T1 (de) Neue peptide
IL193310A0 (en) Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
DE69726602D1 (en) Hepatitis b inhibitoren
EP0717752A4 (de) Therapeitische inhaltsstoffe
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
DZ2803A1 (fr) Polypeptide de la protéine c humaine.
DE59609353D1 (de) Mittel zur subkutanen Verabreichung von Protein C
IT1283883B1 (it) Peptidi derivati da cd4, analoghi e usi di essi in diagnosi e terapia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties